These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 2793517)

  • 21. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mental health conditions among atomic bomb survivors in Nagasaki.
    Honda S; Shibata Y; Mine M; Imamura Y; Tagawa M; Nakane Y; Tomonaga M
    Psychiatry Clin Neurosci; 2002 Oct; 56(5):575-83. PubMed ID: 12193250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The long-term outcome of atomic bomb survivors with gastric carcinoma.
    Yamamoto M; Matsuyama A; Kameyama T; Okamoto M; Okazaki J; Utsunomiya T; Tsutsui S; Ishida T
    J Surg Oncol; 2009 Dec; 100(7):594-7. PubMed ID: 19731244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
    Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
    Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometry measurements of subsets of T, B and NK cells in peripheral blood lymphocytes of atomic bomb survivors.
    Kusunoki Y; Kyoizumi S; Hirai Y; Suzuki T; Nakashima E; Kodama K; Seyama T
    Radiat Res; 1998 Aug; 150(2):227-36. PubMed ID: 9692368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Excess Risk of Heart Disease Mortality among Hiroshima Atomic Bomb Male Survivors Exposed Near the Hypocenter.
    Hara N; Satoh K; Otani K; Kawakami H; Ohtaki M
    Hiroshima J Med Sci; 2016 Sep; 65(2):45-51. PubMed ID: 29989684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukemia: lessons from the Japanese experience.
    Finch SC
    Stem Cells; 1997; 15 Suppl 2():135-9. PubMed ID: 9368297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Male breast cancer incidence among atomic bomb survivors.
    Ron E; Ikeda T; Preston DL; Tokuoka S
    J Natl Cancer Inst; 2005 Apr; 97(8):603-5. PubMed ID: 15840883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection, follow-up, and analysis in the Atomic Bomb Casualty Commission Study.
    Jablon S
    Natl Cancer Inst Monogr; 1985 May; 67():53-8. PubMed ID: 4047151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of radiation on incidence of primary liver cancer among atomic bomb survivors.
    Cologne JB; Tokuoka S; Beebe GW; Fukuhara T; Mabuchi K
    Radiat Res; 1999 Oct; 152(4):364-73. PubMed ID: 10477913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of dementia among atomic-bomb survivors--Radiation Effects Research Foundation Adult Health Study.
    Yamada M; Kasagi F; Mimori Y; Miyachi T; Ohshita T; Sasaki H
    J Neurol Sci; 2009 Jun; 281(1-2):11-4. PubMed ID: 19327783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of HER2 and C-MYC oncogene amplifications in breast cancer in atomic bomb survivors: associations with radiation exposure and histologic grade.
    Miura S; Nakashima M; Ito M; Kondo H; Meirmanov S; Hayashi T; Soda M; Matsuo T; Sekine I
    Cancer; 2008 May; 112(10):2143-51. PubMed ID: 18348306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima.
    Kodama Y; Ohtaki K; Awa AA; Nakano M; Itoh M; Nakamura N
    Radiat Res; 1999 Nov; 152(5):558-62. PubMed ID: 10521934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of atherosclerosis in relation to atomic bomb radiation exposure: an RERF Adult Health Study.
    Yamada M; Naito K; Kasagi F; Masunari N; Suzuki G
    Int J Radiat Biol; 2005 Nov; 81(11):821-6. PubMed ID: 16484151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A regression analysis on the mortality of the Hiroshima atomic bomb survivors.
    Watanabe M
    Hiroshima J Med Sci; 1970 Sep; 19(2):119-23. PubMed ID: 5512079
    [No Abstract]   [Full Text] [Related]  

  • 36. High Initial-dose Dependency of Cerebrovascular Disease Mortality among Female Survivors of the Hiroshima Atomic Bomb Exposed in Teens: A Cohort Study, 1970-2010.
    Matsuba J; Otani K; Satoh K; Kawakami H; Ohtaki M
    Hiroshima J Med Sci; 2016 Sep; 65(2):35-43. PubMed ID: 29989683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow.
    Ichimaru M; Ishimaru T; Mikami M; Matsunaga M
    J Natl Cancer Inst; 1982 Aug; 69(2):323-8. PubMed ID: 6955540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies and immunoglobulins among atomic bomb survivors.
    Fujiwara S; Carter RL; Akiyama M; Akahoshi M; Kodama K; Shimaoka K; Yamakido M
    Radiat Res; 1994 Jan; 137(1):89-95. PubMed ID: 8265792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of cancer and non-cancer diseases in the atomic bomb survivors.
    Ozasa K; Shimizu Y; Sakata R; Sugiyama H; Grant EJ; Soda M; Kasagi F; Suyama A
    Radiat Prot Dosimetry; 2011 Jul; 146(1-3):272-5. PubMed ID: 21502293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased proportion of CD4 T cells in the blood of atomic bomb survivors with myocardial infarction.
    Kusunoki Y; Kyoizumi S; Yamaoka M; Kasagi F; Kodama K; Seyama T
    Radiat Res; 1999 Nov; 152(5):539-43. PubMed ID: 10521931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.